mRNA vaccine for cancer immunotherapy.
Mol Cancer. 2021 Feb 25;20(1):41. doi: 10.1186/s12943-021-01335-5.
Mol Cancer. 2021.
PMID: 33632261
Free PMC article.
Review.
However, mRNA vaccine applications have been limited by instability, innate immunogenicity, and inefficient in vivo delivery. ...This review provides a detailed overview of the recent progress and existing challenges of mRNA cancer vaccines and future conside …
However, mRNA vaccine applications have been limited by instability, innate immunogenicity, and inefficient in vivo delivery. …